Detalles de la búsqueda
1.
Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.
Blood
; 127(20): 2411-5, 2016 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968534
2.
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Oncol
; 18(3): 297-311, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28139405
3.
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.
Lancet Haematol
; 6(7): e366-e374, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31109827
Resultados
1 -
3
de 3
1
Próxima >
>>